# EDGAR Filing Document

**Accession Number:** 0000883107
**File Stem:** 0000950170-25-083345
**Filing Date:** 2025-6
**Character Count:** 7935
**Document Hash:** ec2ea168c36bd71fb84d7ca6a3a2877c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-083345.hdr.sgml**: 20250606

**ACCESSION NUMBER**: 0000950170-25-083345

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250605

**FILED AS OF DATE**: 20250606

**DATE AS OF CHANGE**: 20250606

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Cureton Kevin
- **CENTRAL INDEX KEY:** 0001563513

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42589
- **FILM NUMBER:** 251032449

**MAIL ADDRESS:**
- **STREET 1:** 1319 MARQUETTE DRIVE
- **CITY:** ROMEOVILLE
- **STATE:** IL
- **ZIP:** 60446
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SOLESENCE, INC.
- **CENTRAL INDEX KEY:** 0000883107
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 363687863
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1319 MARQUETTE DRIVE
- **CITY:** ROMEOVILLE
- **STATE:** IL
- **ZIP:** 60446
- **BUSINESS PHONE:** 6307716078

**MAIL ADDRESS:**
- **STREET 1:** 1319 MARQUETTE DRIVE
- **CITY:** ROMEOVILLE
- **STATE:** IL
- **ZIP:** 60446

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NANOPHASE TECHNOLOGIES Corp
- **DATE OF NAME CHANGE:** 20160208

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NANOPHASE TECHNOLOGIES CORPORATION
- **DATE OF NAME CHANGE:** 19970305

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Cureton Kevin<br><sub>(Last) (First) (Middle)</sub><br>1319 MARQUETTE DRIVE<br><sub>(Street)</sub><br>ROMEOVILLE, IL 60446<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-05 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Operating Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>SOLESENCE, INC. [ NANX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock |  |  |  |  |  |  |  | 192212 | D |  |
| Common Stock | 2025-06-05 |  | M |  | 4693 | A | $0.42 | 196905 | D |  |
| Common Stock | 2025-06-05 |  | S |  | 4693<sup>(1)</sup> | D | $3.96 | 192212 | D |  |
| Common Stock | 2025-06-06 |  | M |  | 38807 | A | $0.42 | 231019 | D |  |
| Common Stock | 2025-06-06 |  | S |  | 38807<sup>(1)(2)</sup> | D | $3.8 | 192212 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Common Stock (right to purchase) | $0.68 |  |  |  |  |  |  | 2018-02-21<sup>(3)</sup> | 2027-02-21 | Common Stock | 50000 |  | 50000 | D |  |
| Common Stock (right to purchase) | $0.82 |  |  |  |  |  |  | 2019-05-23<sup>(3)</sup> | 2028-05-23 | Common Stock | 80000 |  | 80000 | D |  |
| Common Stock (right to purchase) | $0.51 |  |  |  |  |  |  | 2020-05-22<sup>(3)</sup> | 2029-05-22 | Common Stock | 16500 |  | 16500 | D |  |
| Common Stock (right to purchase) | $0.45 |  |  |  |  |  |  | 2021-06-18<sup>(3)</sup> | 2027-06-18 | Common Stock | 90000 |  | 90000 | D |  |
| Common Stock (right to purchase) | $4.17 |  |  |  |  |  |  | 2022-12-28<sup>(3)</sup> | 2028-12-28 | Common Stock | 90000 |  | 90000 | D |  |
| Common Stock (right to purchase) | $1.165 |  |  |  |  |  |  | 2023-12-20<sup>(3)</sup> | 2029-12-20 | Common Stock | 72000 |  | 72000 | D |  |
| Common Stock (right to purchase) | $0.61 |  |  |  |  |  |  | 2024-12-27<sup>(3)</sup> | 2030-12-27 | Common Stock | 12600 |  | 12600 | D |  |
| Common Stock (right to purchase) | $2.44 |  |  |  |  |  |  | 2025-12-31<sup>(3)</sup> | 2031-12-31 | Common Stock | 22500 |  | 22500 | D |  |
| Common Stock (right to purchase) | $0.42 | 2025-06-05 |  | M |  |  | 4693 | 2017-02-23<sup>(3)</sup> | 2026-02-23 | Common Stock | 4693 | $0.42 | 0 | D |  |
| Common Stock (right to purchase) | $0.42 | 2025-06-06 |  | M |  |  | 38807 | 2017-02-23<sup>(3)</sup> | 2026-02-23 | Common Stock | 38807 | $0.42 | 0 | D |  |

---

### Footnotes:

(1) These 4,693 shares were sold through fifty trades at prices ranging from $3.95 to $3.99 per share.  The average of all trades was $3.96 per share as shown.

(2) These 38,807 shares were sold through one hundred forty-seven trades at prices ranging from $3.75 to $3.92 per share.  The average of all trades was $3.80 per share as shown.

(3) Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

**Signature:** /s/ Jess Jankowski under UPA for Kevin Cureton  
**Date:** 2025-06-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**